Literature DB >> 8420359

Traction retinal detachment. XLIX Edward Jackson Memorial Lecture.

S J Ryan1.   

Abstract

This review had two main objectives. The first goal was to attempt to define a final common pathway for traction retinal detachment. To illustrate this, I considered the following three common clinical entities: penetrating ocular trauma, proliferative vitreoretinopathy, and proliferative diabetic retinopathy. My second goal was to emphasize the role of research in developing a rational approach to treatment. To illustrate the second goal, I reviewed the contributions from three realms of research--laboratory, animal, and clinical research--examining their interactions and considering their roles in our current understanding and management of these clinical entities.

Entities:  

Mesh:

Year:  1993        PMID: 8420359     DOI: 10.1016/s0002-9394(14)73518-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  Retinal detachment after posterior segment intraocular foreign body injuries.

Authors:  A M El-Asrar; S A Al-Amro; N M Khan; D Kangave
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Growth factors outside the PDGF family drive experimental PVR.

Authors:  Hetian Lei; Gisela Velez; Peter Hovland; Tatsuo Hirose; Debra Gilbertson; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

3.  Evidence of cross-link formation of vitreous collagen during experimental ocular inflammation.

Authors:  T Hikichi; N Ueno; B Chakrabarti; C L Trempe; A Yoshida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

4.  N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy.

Authors:  Hetian Lei; Gisela Velez; Jing Cui; Arif Samad; David Maberley; Joanne Matsubara; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

5.  Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.

Authors:  Murat Atabey Ozer; Nihat Polat; Serkan Ozen; Tevfik Ogurel; Hakan Parlakpinar; Nigar Vardi
Journal:  Int Ophthalmol       Date:  2016-08-05       Impact factor: 2.031

6.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

7.  A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy.

Authors:  Steven Pennock; Marc-Andre Rheaume; Shizuo Mukai; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2011-10-28       Impact factor: 4.307

8.  Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy.

Authors:  G A Limb; A H Chignell; H Woon; W Green; C J Cole; D C Dumonde
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

9.  Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.

Authors:  Hetian Lei; Marc-André Rhéaume; Gisela Velez; Shizuo Mukai; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-24       Impact factor: 4.799

10.  Elevated proto-oncogene and collagen mRNA expression in PVR retinas.

Authors:  Margrit Hollborn; Frank Faude; Peter Wiedemann; Leon Kohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.